Clin2
NCT06994897Possibly a fitRecruiting

Safety and dosing study of PF-07985631 in healthy adults

Healthy

This study tests a new medicine called PF-07985631 in healthy adults to see how different amounts are tolerated and processed by the body. It includes specific groups for Japanese and Chinese participants.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
92 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 45 years old (or up to 55 if you are Japanese or Chinese in certain groups) and generally healthy.
  • You have no history of serious illnesses like heart, kidney, liver, or lung disease, and no allergies to similar medicines.
  • You have not had any infection requiring treatment in the last month, no active infections, and no history of tuberculosis.
  • You have not had a fever in the last week, and no active stomach ulcers or bleeding.
  • You have not received any vaccines in the last 6 weeks and do not plan to get any during the study.
  • You are not taking any illegal drugs, and your blood pressure, kidney function, and lab tests are within normal limits.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07235163Recruiting· Phase 1
Testing a new medicine in healthy adults

This study tests how a new medicine, PF-08065010, is handled by the body and how safe it is in healthy adults. It helps researchers find the right dose for future studies.

Brussels, Bruxelles-capitale, Région de
NCT07725809Not yet recruiting· Phase 1
Study of a new medicine for adults with overweight or obesity

This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.

Brussels, Bruxelles-capitale, Région de
NCT07519135Recruiting· Phase 1
Study of PF-08653944 in People With and Without Liver Problems

This is an early-stage study testing a new medicine called PF-08653944 in healthy adults and in people with varying degrees of liver function problems. The goal is to understand how the medicine works in the body and how liver function affects how the body processes it.

Miami Lakes, Florida
NCT07046559Recruiting· Phase 1
Testing a new drug's safety in healthy volunteers

This trial is testing an experimental drug called LY4066708 in healthy people to see how safe it is and how the body processes it. It may help researchers understand if the drug can be used in future studies for conditions like Alzheimer's disease.

Holbeck, Leeds
NCT06926218Not yet recruiting· Phase 1
Safety study of HSK47388 in healthy adults

This first-in-human trial tests a new medication called HSK47388 in healthy volunteers to see if it's safe and how the body processes it. If you're generally healthy, you may be able to help researchers understand this potential new treatment.

Adelaide
NCT06995820Recruiting· Phase 1
Safety study of AZD1613 in healthy volunteers

This is a first-in-human trial testing an experimental drug (AZD1613) in healthy volunteers. It helps doctors see if the drug is safe, how it is processed by the body, and how the immune system reacts. The trial is designed for healthy men and women who cannot become pregnant and may require participants to be of Chinese or Japanese descent for certain groups.

Glendale, California

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.